ICU Medical Inc. (ICUI) Price to Earnings Ratio

ICU Medical Corp - graphic logo of issuer ICUI

ICU Medical, Inc. (ICUI) is expanding its network of consumables manufacturing plants, although it faces rising raw material costs and lawsuits. Regarding the P/E market valuation in the GURU.Markets system, this chart shows the metric value is 74.20. Business stability relies on a balanced portfolio of infusion systems and intensive care equipment achieved through strategic mergers.

ICU Medical (ICUI) - P/E Multiple from 07/04/2022 to 11/12/2026

Analytical breakdowns for ICU Medical, Inc.

- price and consensus price forecast:
Stock Price icumed.com|ICUI - Price Target Chart
- market capitalization details:
Market Value ICU Medical, Inc.|ICUI - Real Price to Acquire Entire Company
- book capitalization information:
Accounting Value of a Share ICU Medical|ICUI - Book Capitalization|Market Capitalization to Book Value icumed.com|ICUI - Aggregate Company Assets
- debt obligations and liquidity statistics:
Debt to Equity Ratio ICU Medical, Inc.|ICUI - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient ICU Medical Inc.|ICUI - Company Total Debt|Debt to Book Capital ICU Medical, Inc.|ICUI - Company Long-Term Debt|Company Short-Term Loans and Borrowings ICU Medical|Quick Ratio icumed.com
- earnings and valuation multiples indicators:
ICUI - Company Net Income|Future Profit ICU Medical, Inc.|ICUI - P/E Multiple|Projected Price to Earnings Ratio ICU Medical Inc|ICUI - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation ICU Medical, Inc.|ICUI - Operating profit before deduction of amortization|Earnings per share for the last four quarters ICU Medical|ICUI - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months icumed.com|ICUI - Earnings growth in current year|Consensus forecast of earnings per share growth for next year ICU Medical, Inc.
General company analysis:icumed.com, ICUI
Product sample of ICU Medical, Inc.

Professional managers utilize fundamental multiples to verify an asset's market value relative to its actual yield. This P/E ratio based on net income measures the cost of one dollar of profit, allowing for an assessment of the premium the market assigns to the impeccable reputation of ICU Medical, Inc. (ICUI) within the critical care medicine and infusion system safety sector.

Analysis of competing companies

P/E Multiple intuitive.com|Price to Earnings Ratio Danaher (DHR)|Price to Earnings Ratio BDX (BD)|STERIS Corporation - Price to Earnings Ratio|Company Value to Net Income WST|Baxter International - P/E Multiple|Business Payback Period masimo.com MASI|Stevanato Group (STVN) - Price to Earnings Ratio|Price to Earnings Multiple TFX|Price to Earnings Ratio Merit Medical Systems Inc|Nobel Biocare (NVST) - Business Payback Period|Price to Earnings Ratio XRAY (DENTSPLY SIRONA Inc.)|Market Price to Net Income Ratio LMAT|Price to Earnings Ratio AtriCure ATRC|Company Value to Net Income STAA|NAGE: Price to Earnings Ratio|ZIMV - P/E Multiple|AngioDynamics, Inc. (ANGO) - Price to Earnings Ratio|Price to Earnings Ratio cerus.com|TKNO (Teknova) - P/E Multiple|Market Cap to Earnings Monogram Technologies Inc. MGRM|Price to Earnings Ratio Sharps Technology, Inc. (STSS)|infusystem.com - Price to Earnings Multiple|Utah Medical Products - Price to Earnings Ratio|Market Price to Net Income Ratio KRMD (KORU Medical Systems, Inc.)|NYXH - Price to Earnings Ratio|Business Payback Period Microbot Medical, Inc. MBOT|PDEX: P/E Multiple|ZTEK - Business Payback Period|ELUT (Elutia Inc.) - P/E Multiple|Price to Earnings Ratio milestonescientific.com (MLSS)|Price to Earnings Ratio NXGL (NEXGEL)|P/E Multiple retractable.com (RVP)|Harvard Bioscience - Price to Earnings Ratio|Company Value to Net Income FEMY|MHUA - Price to Earnings Ratio|Predictive Oncology (POAI) - Price to Earnings Ratio|CJMB: P/E Multiple|Market Cap to Earnings Atrion Corp. (ATRI)|NURO (NeuroMetrix Corp) - P/E Multiple